FDA Approved: TZIELD — Supplemental Application (Provention Bio, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for TZIELD (teplizumab-mzwv) from Provention Bio, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• TZIELD (TEPLIZUMAB-MZWV)

Snippet

SUPPL AP for TZIELD (TEPLIZUMAB-MZWV)